Engineering 3D printed tablets of amorphous solid dispersions of irbesartan for immediate release: overcoming printability limitations and enhancing dissolution performance
RSC Pharmaceutics · 2026
DOI: 10.1039/d6pm00356g ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Pharmaceutics, 2026. Verfasst von Tikeshwar und 4 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India.
Abstract (Originalsprache)
Irbesartan-loaded filaments were produced via hot-melt extrusion (HME) using Kollicoat® IR and SmartEx® QD and fabricated into immediate-release tablets through fused deposition modelling (FDM) 3D printing.
Förderung
- Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India
Zitieren
APA
Tikeshwar, Chilamakuri, S. N., Methri, S. K., N, M., & Natesan, S. (2026). Engineering 3D printed tablets of amorphous solid dispersions of irbesartan for immediate release: overcoming printability limitations and enhancing dissolution performance. RSC Pharmaceutics. https://doi.org/10.1039/d6pm00356g
Vancouver
Tikeshwar, Chilamakuri SN, Methri SK, N M, Natesan S. Engineering 3D printed tablets of amorphous solid dispersions of irbesartan for immediate release: overcoming printability limitations and enhancing dissolution performance. RSC Pharmaceutics. 2026. doi:10.1039/d6pm00356g
BibTeX
@article{Tikeshwar2026,
author = {Tikeshwar and Chilamakuri, Sudarshan Naidu and Methri, Shiva Kumar and N, Manasa and Natesan, Subramanian},
title = {Engineering 3D printed tablets of amorphous solid dispersions of irbesartan for immediate release: overcoming printability limitations and enhancing dissolution performance},
journal = {RSC Pharmaceutics},
year = {2026},
doi = {10.1039/d6pm00356g}
}
EUVIMED